192 related articles for article (PubMed ID: 1801455)
1. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
Kulikov VI; Muzia GI
Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
[TBL] [Abstract][Full Text] [Related]
2. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
3. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
Kecskeméti V; Balogh I
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
[TBL] [Abstract][Full Text] [Related]
4. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
Koltai M; Hosford D; Braquet P
J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
[No Abstract] [Full Text] [Related]
5. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
Lohde C; Bahr T; Labes D; Grupe R
Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
[TBL] [Abstract][Full Text] [Related]
6. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
7. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
Bazan HE; Tao Y
J Ocul Pharmacol Ther; 1997 Jun; 13(3):277-85. PubMed ID: 9185044
[TBL] [Abstract][Full Text] [Related]
8. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
Heinroth-Hoffmann I; Hauser A; Mest HJ
Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
[TBL] [Abstract][Full Text] [Related]
9. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436
[No Abstract] [Full Text] [Related]
10. PAF antagonism as an approach to the treatment of airway hyperreactivity.
Meade CJ; Heuer H
Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
[TBL] [Abstract][Full Text] [Related]
11. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
[No Abstract] [Full Text] [Related]
12. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
[TBL] [Abstract][Full Text] [Related]
13. The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm.
Mest HJ; Riedel A; Meyer E; Hoffmann IH; Mentz G; Mentz P; Tschorn W; Sperling J
Prog Clin Biol Res; 1989; 301():475-9. PubMed ID: 2798457
[No Abstract] [Full Text] [Related]
14. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF).
Teixeira CF; Cury Y; Oga S; Jancar S
Toxicon; 1994 Apr; 32(4):419-26. PubMed ID: 8052996
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
16. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
Koltai M; Pirotzky E; Braquet P
Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
[No Abstract] [Full Text] [Related]
17. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
Dive G; Godfroid JJ; Lamotte-Brasseur J; Batt JP; Heymans F; Dupont L; Braquet P
J Lipid Mediat; 1989; 1(4):201-15. PubMed ID: 2562434
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet activating factor antagonists in different models of thrombosis.
Seth P; Kumari R; Dikshit M; Srimal RC
Thromb Res; 1994 Dec; 76(6):503-12. PubMed ID: 7900097
[TBL] [Abstract][Full Text] [Related]
19. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
20. Enterolobin induces rat paw oedema independently of PAF-acether.
Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
